Abiopharma

News list

Director MORIKIS JOHN G 🟢 acquired 1.5K shares (1 derivative) of JOHNSON & JOHNSON (JNJ) Transaction Date: Apr 23, 2026 | Filing ID: 000104

Full text

News bot April 27, 2026, 10:12 p.m.
🔍 MORIKIS JOHN G (Director)

Company: JOHNSON & JOHNSON (JNJ)

Report Date: 2026-04-23
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,540
Detailed Transactions and Holdings:
- Acquired 1,540 shares of Deferred Share Units (Derivative)
  Date: 2026-04-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,540.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
Footnotes:
- F1: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).